查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1877388

个人化医疗奈米材料市场：按应用领域、终端用户、奈米材料类型、所用技术和地区划分－全球产业分析、市场规模、市场份额及2025-2032年预测

Nanomaterials In Personalized Medicine Market, By Application Areas, By End-users, By Type of Nanomaterials, By Technology Utilized, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年个人化医疗奈米材料市场规模为 3554.5634 亿美元，从 2025 年到 2032 年以 11.5% 的复合年增长率成长。

个人化医疗中的奈米材料是指能够以精确可控的方式与生物系统相互作用的奈米级工程物质，它能够根据个体的特定基因、分子或生理特征量身定制医疗干预措施。慢性病盛行率的上升和奈米技术的进步是推动奈米材料应用的主要动力，但高昂的研发成本和监管障碍是重要的阻碍因素。然而，开发具有更优异性能的新型奈米材料、利用人工智慧进行药物研发以及拓展新兴市场都蕴藏着巨大的机会。製药公司、生技公司和学术机构之间的策略合作对于克服这些障碍、实现市场潜力至关重要。

个人化医疗中的奈米材料市场－市场动态

个人化医疗需求不断成长推动市场发展

未来几年，个人化医疗需求的不断增长预计将推动奈米材料在个人化医疗市场的发展。个人化医疗是一种医疗方法，它根据患者的遗传、环境和生活方式因素，量身定制治疗方案，以优化治疗效果并改善护理。随着基因组技术的进步，精准识别基因变异并为个体制定个人化治疗方案成为可能，个人化医疗的需求也日益增长。奈米材料透过实现标靶和患者特异性治疗，提升了个人化医疗的疗效和安全性。它们能够实现药物、基因或RNA的标靶递送，从而降低副作用并改善治疗效果。据总部位于美国的非营利组织个人化医疗联盟（PMC）称，美国食品药物管理局（FDA）在2023年批准了26种新的个人化药物，高于2022年的12种。因此，对个人化医疗日益增长的需求正在推动个人化医疗产业中奈米材料的发展。

个人化医疗奈米材料市场細項分析：

全球市场按应用领域、最终用户、奈米材料类型、所用技术、配方类型和地区进行细分。

製剂种类主要分为奈米颗粒、奈米晶体、奈米悬浮液、奈米乳剂和标靶递送奈米製剂。其中，奈米颗粒是奈米材料市场中个人化医疗的关键组成部分，在标靶药物递送、癌症治疗和诊断方面发挥着至关重要的作用。它们能够克服生物屏障，并将治疗药物精准地递送至病变细胞，使其成为各种医疗应用的理想选择。例如，2025年4月，Marama Labs推出了CloudSpec，这是一款能够加速脂质奈米颗粒中药物有效载荷定量分析的仪器，可在15秒内完成RNA或DNA的精确测量。

从应用领域来看，药物递送系统是奈米材料在个人化医疗市场中最重要的细分领域之一，因为奈米载体（尤其是脂质奈米颗粒，即LNP）能够将包括mRNA、siRNA和基因编辑剂在内的个人化疗法精准、安全、高效地递送至目标细胞，同时保护脆弱的核酸并最大限度地减少脱靶效应。 Acuitas Therapeutics就是一个引人注目的例子，该公司是LNP递送技术的先驱。在2025年的ASGCT年会上，Acuitas展示了下一代LNP的临床前资料，该LNP采用DARPin偶联配体，可将mRNA有效载荷定向递送至T细胞，并验证了重复给药的安全性以及肝臟以外的靶向性。 2024年5月，Aldevron宣布与Acuitas建立策略伙伴关係，部署其LNP平台进行mRNA从序列到製剂的生产，从而显着提高个人化RNA疗法的产能。

个人化医疗奈米材料市场—地域性洞察

亚太地区在个人化医疗奈米材料市场占据显着份额，这得益于政府的大力支持、不断完善的生物技术基础设施以及医疗保健投资的增加。中国、印度、日本和韩国等国家处于领先地位，其国家级计画大力支持奈米技术研究和精准医疗的发展。疾病盛行率的上升，尤其是慢性病和遗传性疾病，推动了对个人化奈米药物的需求成长。该地区不断壮大的中产阶级，以及先进医疗保健服务的普及，促进了奈米技术在诊断和治疗领域的应用。亚太地区正迅速成为创新和成长的关键市场，研发和商业化能力都在快速扩张。

日本奈米材料在个人化医疗市场的应用—国家概况

由于政府大力支持研发以及完善的生物技术基础设施，日本正崛起为奈米医学创新的重要中心。日本奈米医学学会鼓励学术界、产业界和医疗机构合作，以推动基于奈米材料的个人化医疗疗法。 2024年4月，芬兰奈米製药公司Nanoform与日本製药公司CBC株式会社达成策略合作，将Nanoform的奈米颗粒工程平台引进日本。此举旨在提高药物的生物利用度，并降低日本患者的用药剂量。此外，位于川崎的奈米医学创新中心（iCONM）正引领着前沿研究：2025年中期，一个研究团队开发出一种奈米药物，可将反义核酸递送至淋巴结，进而抑制癌症转移。

个人化医疗奈米材料市场竞争格局：

个人化医疗奈米材料市场的竞争格局集中度适中，主要参与者包括赢创工业集团（Evonik Industries AG）、OncoNano Medicine Inc. 和默克集团（Merck KGaA）。赢创致力于开发用于癌症治疗的脂质奈米载体，而OncoNano Medicine则专注于用于精准药物递送和成像的金奈米颗粒平台。默克集团则利用聚合物基奈米材料进行标靶基因治疗和个人化预防。这些公司竞相提升奈米载体的生物相容性、稳定性和标靶能力。策略合作、临床协作和规模化生产计画均有助于推动创新。随着对客製化治疗的需求不断增长，各公司优先考虑研发投入和商业化策略，以保持其在精准奈米医学领域的领先地位。

目录

第一章：个人化医疗中的奈米材料市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 奈米材料在个人化医疗市场的应用领域概览
    • 个人化医疗奈米材料市场概览（按终端用户划分）
    • 个人化医疗中的奈米材料市场概览（按奈米材料类型划分）
    • 个人化医疗中的奈米材料市场概览（按所用技术划分）
    • 个人化医疗奈米材料市场概览（按製剂类型划分）
    • 奈米材料在个人化医疗市场的应用（按国家/地区划分）
    • 个人化医疗奈米材料市场概览（按地区划分）
  • 竞争洞察

第三章：奈米材料在个人化医疗中的应用－关键市场趋势

  • 个人化医疗中的奈米材料市场驱动因素
    • 市场驱动因素的影响分析
  • 奈米材料在个人化医疗市场中的限制因素
    • 市场限制因素的影响分析
  • 奈米材料在个人化医疗中的市场机会
  • 奈米材料在个人化医疗市场的未来趋势

第四章：奈米材料在个人化医疗产业的应用研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：个人化医疗市场中的奈米材料：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：奈米材料在个人化医疗市场的应用概况

  • 2024年个人化医疗奈米材料市场份额分析
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：奈米材料在个人化医疗市场的应用－依应用领域划分

  • 概述
    • 按应用领域分類的细分市场占有率分析
    • 药物输送系统
    • 再生医学
    • 诊断和影像
    • 疗法
    • 疫苗

第八章：奈米材料在个人化医疗市场的应用－以终端使用者划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊所
    • 生技公司
    • 学术机构
    • 研究实验室
    • 製药公司

第九章：个人化医疗市场中的奈米材料－以奈米材料类型划分

  • 概述
    • 按奈米材料类型分類的细分市场份额分析
    • 碳基奈米材料
    • 奈米结构材料
    • 金属奈米粒子
    • 聚合物奈米材料
    • 二氧化硅奈米颗粒

第十章：个人化医疗市场中的奈米材料－依所采用的技术划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 奈米加工技术
    • 分子影像技术
    • 基于奈米技术的筛选方法
    • 生物偶联方法
    • 表面改质技术

第十一章：个人化医疗市场中的奈米材料－以製剂类型划分

  • 概述
    • 按配方类型分類的细分市场份额分析
    • 奈米颗粒
    • 奈米晶体
    • 奈米悬浮液
    • 奈米乳液
    • 用于标靶递送的奈米製剂

第十二章：个人化医疗市场中的奈米材料－依地域划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美个人化医疗奈米材料主要生产商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（按应用领域划分）
    • 北美市场规模及预测（依最终用户划分）
    • 北美奈米材料市场规模及预测（按奈米材料类型划分）
    • 北美市场规模及预测（依所用技术划分）
    • 北美市场规模及预测（依製剂类型划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲个人化医疗奈米材料主要生产商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（按应用领域划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 欧洲奈米材料市场规模及预测（按奈米材料类型划分）
    • 欧洲市场规模及预测（依所用技术划分）
    • 欧洲市场规模及预测（依製剂类型划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区个人化医疗奈米材料主要生产商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依应用领域划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 亚太地区奈米材料市场规模及预测（依奈米材料类型划分）
    • 亚太地区市场规模及预测（依所用技术划分）
    • 亚太地区市场规模及预测（依製剂类型划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 个人化医疗中的奈米材料：拉丁美洲主要生产商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（按应用领域划分）
    • 拉丁美洲市场规模及预测（按最终用户划分）
    • 拉丁美洲奈米材料市场规模及预测（按奈米材料类型划分）
    • 拉丁美洲市场规模及预测（依所用技术划分）
    • 拉丁美洲市场规模及预测，依製剂类型划分
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 个人化医疗中的奈米材料：中东和非洲的主要生产商
    • 中东和非洲市场规模及预测（按国家/地区划分）
    • 中东和非洲市场规模及预测（按应用领域划分）
    • 中东和非洲市场规模及预测（按最终用户划分）
    • 中东和非洲奈米材料市场规模及预测（按奈米材料类型划分）
    • 中东和非洲市场规模及预测（按所用技术划分）
    • 中东和非洲市场规模及预测（按製剂类型划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十三章：关键供应商分析－个人化医疗产业的奈米材料

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Merck KGaA Darmstadt Germany
    • OncoNano Medicine Inc.
    • Molecular Rebar Design Inc
    • Cello Therapeutics Inc.
    • Evonik Industries AG
    • Eisai Co. Ltd.
    • TUV Rheinland AG
    • OCSiAl SA
    • Sanofi SA
    • The Bristol-Myers Squibb Company
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • American Elements Inc.
    • Pfizer & Co. Inc
    • BASF SE
    • Cour Pharmaceuticals Inc.
    • Nanocomposix Inc
    • NoPo Nanotechnologies Private Limited
    • Matexcel Biotech Inc.
    • Apurano Pharmaceuticals GmbH
    • SGN Nanopharma Inc.
    • Others

第十四章：360度分析师视角

第十五章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5747

The Nanomaterials In Personalized Medicine Market size was valued at US$ 355,456.34 Million in 2024, expanding at a CAGR of 11.5% from 2025 to 2032.

Nanomaterials in personalized medicine are nanoscale-engineered substances that interact with biological systems in a precise and controlled manner, allowing healthcare interventions to be tailored to an individual's specific genetic, molecular, or physiological characteristics. The rising prevalence of chronic diseases and advances in nanotechnology are major motivators, but high development costs and regulatory hurdles are significant impediments. However, opportunities exist for the development of novel nanomaterials with improved properties, the use of AI in drug discovery, and expansion into emerging markets. Strategic collaborations between pharmaceutical companies, biotechnology firms, and academic institutions are critical for overcoming these obstacles and realizing market potential.

Nanomaterials In Personalized Medicine Market- Market Dynamics

Increasing Demand for Personalized Medicine Fueling the Market Growth

The rising demand for personalized medicine is expected to drive the growth of nanomaterials in the personalized medicine market in the coming years. Personalized medicine is a medical approach in which treatments are tailored to individual patients based on genetic, environmental, and lifestyle factors in order to optimize outcomes and improve care. The demand for personalized medicine is growing as genomic technologies advance, allowing for the precise identification of genetic variations and tailored treatments for individuals. Nanomaterials improve personalized medicine by allowing for targeted and patient-specific therapies, which improves treatment efficacy and safety. They enable targeted delivery of drugs, genes, or RNA, lowering side effects and improving therapeutic outcomes. According to the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. As a result, the growing demand for personalized medicine is driving the development of nanomaterials in the personalized medicine industry.

Nanomaterials In Personalized Medicine Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Application Areas, End-users, Type of Nanomaterials, Technology Utilized, Formulation Type, and Region.

The Formulation Type segment is primarily categorized into Nanoparticles, Nanocrystals, Nanosuspensions, Nanoemulsions, and Nanoformulations for Targeted Delivery. Among which. Nanoparticles are a crucial segment in the nanomaterials market for personalized medicine, playing a vital role in targeted drug delivery, cancer treatment and diagnostics. Their ability to overcome biological barriers and deliver therapeutic agents precisely to diseased cells makes them an attractive solution for various medical applications. For instance, in April 2025, Marama Labs launched CloudSpec, an instrument that accelerates quantification of drug payloads in lipid nanoparticles, enabling precise RNA or DNA measurements within 15 seconds.

Based on Application Areas, Drug Delivery Systems are one of the most important segments of the Nanomaterials in Personalized Medicine market because nano-enabled carriers (particularly lipid nanoparticles, or LNPs) enable the precise, safe, and efficient delivery of personalized therapies-including mRNA, siRNA, and gene-editing agents-to the intended cells while protecting fragile nucleic acids and minimizing off-target effects. One compelling example is Acuitas Therapeutics, a pioneer in LNP delivery technology. At the ASGCT annual meeting in 2025, Acuitas presented preclinical data for next-generation LNPs with DARPin-conjugated ligands to direct mRNA payloads to T-cells, as well as repeat dosing safety and targeting beyond the liver. In May 2024, Aldevron announced a strategic partnership with Acuitas to deploy its LNP platform for mRNA sequence-to-vial manufacturing, significantly increasing capacity for personalized RNA therapies.

Nanomaterials In Personalized Medicine Market- Geographical Insights

Asia Pacific has a significant share of the Nanomaterials in personalized medicine Market, owing to strong government initiatives, expanding biotech infrastructure, and increased healthcare investment. Countries such as China, India, Japan, and South Korea are at the forefront, with national programs supporting nanotechnology research and precision medicine development. Rising disease prevalence, particularly in chronic and genetic conditions, drives up demand for personalized nanomedicines. The region's growing middle class, combined with improved access to advanced healthcare, promotes the use of nano-enabled diagnostics and therapeutics. Asia Pacific is becoming a key market for innovation and growth, with rapid expansion in R&D and commercial capacity.

Japan Nanomaterials In Personalized Medicine Market- Country Insights

Japan is emerging as a major hub for nanomedicine innovation, due to strong government R&D support and a well-established biotech infrastructure. The Japan Nanomedicine Society encourages collaboration among academia, industry, and healthcare to advance nanomaterial-based therapies for personalized medicine. In April 2024, Nanoform Finland formed a strategic partnership with Japanese pharmaceutical firm CBC Co., Ltd. to bring Nanoform's nanoparticle-engineering platform to Japan. The goal is to improve drug bioavailability and reduce doses for Japanese patients. Furthermore, the Innovation Center of NanoMedicine (iCONM) in Kawasaki is spearheading cutting-edge research: in mid-2025, a team of researchers developed a nanomedicine that delivers antisense nucleic acids to lymph nodes to suppress cancer metastases.

Nanomaterials In Personalized Medicine Market- Competitive Landscape:

The competitive landscape for Nanomaterials in Personalized Medicine Market is moderately concentrated, with major players including Evonik Industries AG, OncoNano Medicine Inc., and Merck KGaA. Evonik is developing lipid-based nanocarriers for cancer treatments, whereas OncoNano Medicine focuses on gold nanoparticle platforms for precise drug delivery and imaging. Merck KGaA uses polymer-based nanomaterials for targeted gene therapy and personalized prophylactics. These companies compete to improve nanocarriers' biocompatibility, stability, and targeting capabilities. Strategic partnerships, clinical collaborations, and scale-up initiatives all contribute to innovation. As the demand for tailored treatments grows, companies prioritize R&D investment and commercialization strategies to maintain their position as leaders in precision nanomedicine.

Recent Developments:

In June 2023, Bayer AG, a German pharmaceutical and biotechnology company, has partnered with Acuitas Therapeutics Inc. to gain access to its lipid nanoparticle (LNP) delivery technology. This collaboration aims to advance Bayer's in vivo gene editing and protein replacement programs by utilizing Acuitas' lipid nanoparticle technology, which enables efficient and targeted RNA delivery, particularly to the liver. Acuitas Therapeutics Inc. is a Canadian biotechnology company that specializes in lipid nanoparticle (LNP) delivery systems, which are important nanomaterials for personalized medicine.

In September 2023, Evonik improved its parenteral drug delivery solutions with three new PLA-PEG di-block copolymers (RESOMER RP d) and a nanoparticle formulation service based on sonication technology. The copolymers are excellent for nanoparticle formation and controlled drug release applications. The new nanosonication process allows for cGMP production of nanoparticles, addressing production challenges in drug delivery.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Merck KGaA Darmstadt Germany
  • OncoNano Medicine Inc.
  • Molecular Rebar Design Inc
  • Cello Therapeutics Inc.
  • Evonik Industries AG
  • Eisai Co. Ltd.
  • TUV Rheinland AG
  • OCSiAl S.A
  • Sanofi S.A.
  • The Bristol-Myers Squibb Company
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • American Elements Inc.
  • Pfizer & Co. Inc
  • BASF SE
  • Cour Pharmaceuticals Inc.
  • Nanocomposix Inc
  • NoPo Nanotechnologies Private Limited
  • Matexcel Biotech Inc.
  • Apurano Pharmaceuticals GmbH
  • SGN Nanopharma Inc.
  • Others

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY APPLICATION AREAS- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery Systems
  • Regenerative Medicine
  • Diagnostics and Imaging
  • Therapeutics
  • Vaccines

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Biotechnology Firms
  • Academic Institutions
  • Research Laboratories
  • Pharmaceutical Companies

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TYPE OF NANOMATERIALS- MARKET ANALYSIS, 2019 - 2032

  • Carbon-based Nanomaterials
  • Nanostructured Materials
  • Metallic Nanoparticles
  • Polymeric Nanomaterials
  • Silica Nanoparticles

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TECHNOLOGY UTILIZED- MARKET ANALYSIS, 2019 - 2032

  • Nanofabrication Techniques
  • Molecular Imaging Techniques
  • Nanotechnology-based Screening Methods
  • Bioconjugation Methods
  • Surface Modification Techniques

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanoparticles
  • Nanocrystals
  • Nanosuspensions
  • Nanoemulsions
  • Nanoformulations for Targeted Delivery

GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nanomaterials In Personalized Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nanomaterials In Personalized Medicine Market Snippet by Application Areas
    • 2.1.2. Nanomaterials In Personalized Medicine Market Snippet by End-users
    • 2.1.3. Nanomaterials In Personalized Medicine Market Snippet by Type of Nanomaterials
    • 2.1.4. Nanomaterials In Personalized Medicine Market Snippet by Technology Utilized
    • 2.1.5. Nanomaterials In Personalized Medicine Market Snippet by Formulation Type
    • 2.1.6. Nanomaterials In Personalized Medicine Market Snippet by Country
    • 2.1.7. Nanomaterials In Personalized Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Nanomaterials In Personalized Medicine Key Market Trends

  • 3.1. Nanomaterials In Personalized Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nanomaterials In Personalized Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nanomaterials In Personalized Medicine Market Opportunities
  • 3.4. Nanomaterials In Personalized Medicine Market Future Trends

4. Nanomaterials In Personalized Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nanomaterials In Personalized Medicine Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nanomaterials In Personalized Medicine Market Landscape

  • 6.1. Nanomaterials In Personalized Medicine Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nanomaterials In Personalized Medicine Market - By Application Areas

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application Areas, 2024 & 2032 (%)
    • 7.1.2. Drug Delivery Systems
    • 7.1.3. Regenerative Medicine
    • 7.1.4. Diagnostics and Imaging
    • 7.1.5. Therapeutics
    • 7.1.6. Vaccines

8. Nanomaterials In Personalized Medicine Market - By End-users

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
    • 8.1.2. Hospitals & Clinics
    • 8.1.3. Biotechnology Firms
    • 8.1.4. Academic Institutions
    • 8.1.5. Research Laboratories
    • 8.1.6. Pharmaceutical Companies

9. Nanomaterials In Personalized Medicine Market - By Type of Nanomaterials

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type of Nanomaterials, 2024 & 2032 (%)
    • 9.1.2. Carbon-based Nanomaterials
    • 9.1.3. Nanostructured Materials
    • 9.1.4. Metallic Nanoparticles
    • 9.1.5. Polymeric Nanomaterials
    • 9.1.6. Silica Nanoparticles

10. Nanomaterials In Personalized Medicine Market - By Technology Utilized

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
    • 10.1.2. Nanofabrication Techniques
    • 10.1.3. Molecular Imaging Techniques
    • 10.1.4. Nanotechnology-based Screening Methods
    • 10.1.5. Bioconjugation Methods
    • 10.1.6. Surface Modification Techniques

11. Nanomaterials In Personalized Medicine Market - By Formulation Type

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Formulation Type, 2024 & 2032 (%)
    • 11.1.2. Nanoparticles
    • 11.1.3. Nanocrystals
    • 11.1.4. Nanosuspensions
    • 11.1.5. Nanoemulsions
    • 11.1.6. Nanoformulations for Targeted Delivery

12. Nanomaterials In Personalized Medicine Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Nanomaterials In Personalized Medicine Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Nanomaterials In Personalized Medicine Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Nanomaterials In Personalized Medicine Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Nanomaterials In Personalized Medicine Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Nanomaterials In Personalized Medicine Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Nanomaterials In Personalized Medicine Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Merck KGaA Darmstadt Germany
    • 13.2.2. OncoNano Medicine Inc.
    • 13.2.3. Molecular Rebar Design Inc
    • 13.2.4. Cello Therapeutics Inc.
    • 13.2.5. Evonik Industries AG
    • 13.2.6. Eisai Co. Ltd.
    • 13.2.7. TUV Rheinland AG
    • 13.2.8. OCSiAl S.A
    • 13.2.9. Sanofi S.A.
    • 13.2.10. The Bristol-Myers Squibb Company
    • 13.2.11. Thermo Fisher Scientific Inc.
    • 13.2.12. Abbott Laboratories
    • 13.2.13. American Elements Inc.
    • 13.2.14. Pfizer & Co. Inc
    • 13.2.15. BASF SE
    • 13.2.16. Cour Pharmaceuticals Inc.
    • 13.2.17. Nanocomposix Inc
    • 13.2.18. NoPo Nanotechnologies Private Limited
    • 13.2.19. Matexcel Biotech Inc.
    • 13.2.20. Apurano Pharmaceuticals GmbH
    • 13.2.21. SGN Nanopharma Inc.
    • 13.2.22. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us